Introduction
Genome-wide association studies (GWAS) are extensively used to identify single-nucleotide polymorphisms (SNPs) associated with disease risk (Visscher et al. 2012) . Only a fraction (1-4 %) of SNPs detected by candidate gene association studies has been replicated by GWAS (Ioannidis et al. 2011; Siontis et al. 2010) . A typical GWAS includes discovery and replication stage (Kraft and Cox 2008) . Replication is considered to be a gold standard for validation of GWAS-detected associations (Greenwood et al. 2007; Kraft et al. 2009 ). Typically SNPs are selected for replication based on P values from the discovery phase (Hakonarson and Grant 2011; Smith and Newton-Cheh 2009) . Usually, only a fraction of SNPs from the discovery GWAS is replicated in the replication phase. Our analysis of GWAS studies published in Nature Genetics showed a typical inside study replication rate of 1-5 % with the replication rate negatively correlated with the number of SNPs selected for replication. Identification of SNPs with a highest prior probability to be replicated would allow targeting a smaller set of SNPs for replication, reducing the number of statistical tests and increasing power. Because reproducibility rate for SNPs selected based solely on P values is low, additional predictors of SNP reproducibility are needed.
Published studies suggest that a SNP's characteristics influence its chance to be detected and replicated by GWAS. GWAS-detected SNPs tend to influence quantitative trait loci (eQTLs) (Cookson et al. 2009; Nicolae et al. 2010) . Exonic SNPs and SNPs located in 5′ gene regions are detected more often in GWA studies than expected by chance (Schork et al. 2013) .
Thousands of genome-wide association studies have been conducted and the results are reported in several databases. One of the most comprehensive databases is the catalog of published GWASs (CPGWAS) (Hindorff et al. 2009 ) (http://www.genome.gov/gwastudies/). More than 7,000 SNP associated with nearly 5,000 genes have been reported in CPGWAS, making it a valuable resource for studying SNP reproducibility. The goal of our study was to identify SNP features associated with SNP reproducibility.
Materials and methods

Data sources
Disease-associated SNPs used in this analysis came from the Catalog of Published Genome-Wide Association Studies (CPGWAS) (http://www.genome.gov/26525384/). The database was accessed on September 15, 2013. CPG-WAS provides information on studied disease/phenotype. The database also lists SNPs identified by the study, as well as linked genes (Hindorff et al. 2009) . In this study, we focused on SNPs associated with human diseases. The major reason for this was practical significance. Another reason was that characteristics of the disease-associated SNPs may be different from those of the SNPs associated with morphological traits (Alfoldi and Lindblad-Toh 2013) or quantitative traits. Only SNPs mapped to a single gene were used in the analysis. Supplementary Table S1 provides the list of the GWAS-detected disease risk associated SNPs from CPGWAS used in this study.
SNP reproducibility
In total, 106 different diseases targeted by GWASs are reported by CPGWAS. Different diseases are targeted by GWASs a different number of times: for example, there were 29 GWASs on the type 2 diabetes and one GWAS on neonatal lupus. Seventy-four diseases were targeted at least twice. SNPs detected in those studies can be used to assess SNP reproducibility. The list of the human diseases targeted by GWASs and with at least two reported studies can be found in supplementary Table S2 .
To estimate SNP reproducibility, we first sorted GWASs targeting the same phenotype by publication date. A study reporting a SNP for the first time was considered as a discovery. Subsequent studies were considered as replications. We consider consequent studies as replication studies because subsequent studies are likely to include earlier reported SNPs on their genotyping platforms. They also tend to be larger, both in terms of sample size and the number of genotyped SNPs. SNP reproducibility was computed as the ratio of the number of successes (times the SNP was replicated) to the number of attempts at replication, with replication defined as obtaining a P value <5 × 10 −8 in the subsequent study. Therefore, SNP reproducibility varied from 0 to 1. SNP reproducibility was weighted by the number of replication studies; each case was repeated n times in analysis, where n is the number of validation studies.
Variables used as predictors of SNP reproducibility
Based on published evidence as well as results of our pilot analyses, we preselected 13 variables that could influence SNP reproducibility. Table 1 shows the list of the variables. The variables can be divided into SNP-related and generelated groups. SNP-related predictors included −Log(P) from the discovery study, minor allele frequency (MAF), SNP type, e.g., intronic or missense mutations, and SNP eQTL status (whether the SNP is reported among eQTLs detected on HapMap samples). SNP type was defined as it was done in CPGWAS: (listed in alphabetic order): 3′ UTR, 3′ downstream, 5′ upstream, 5′ UTR, coding nonsynonymous, coding synonymous, intergenic, intronic, non-coding, and non-coding intronic. Details on the definition of SNP types can be found in the paper by Ullah et al. (2013) . Gene/protein-related traits included gene size, cellular localization of the gene product, expression pattern (tissue specific versus not), type of encoded protein, e.g., transcription factor, and the level of evolutionary conservation. Data on gene sizes were retrieved from the Gene database (http://www.ncbi.nlm.nih.gov/). We used HomoloGene database (Coordinators 2014 ) (http://www.ncbi.nlm.nih. gov/homologene) to assess the level of evolutionary conservation-conservation index (CI). CI was defined based on the most distant detectable ortholog of the human gene. The CI changes from 1 (gene is unique to Homo sapiens) to 10 (ortholog of the human gene is detected in at least one plant species; see our recent paper (Gorlova et al. 2014 for details). The CI we used was similar to the one used by Domazet-Loso and Tautz (2008) . The Tissue-specific Gene Expression and Regulation (TiGER) database (Liu et al. 2008) : http://bioinfo.wilmer.jhu.edu/tiger/ was used to identify genes having a tissue-specific pattern of the gene expression. Genes reported as tissue specific in TiGER were also considered to be tissue specific in this analysis. Gene categories, e.g., kinases, were retrieved from the Gene Ontology (GO) database (Balakrishnan et al. 2013) .
We estimated the association between SNP reproducibility and individual predictors listed in Table 1 . Oneway analysis of variance (ANOVA) was used in univariate analysis. Scatterplots were utilized to visualize association between individual predictors and SNP reproducibility. Main-effects ANOVA was used to identify a subset of variables independently predicting SNP reproducibility.
An important goal of this study was to develop a simple, easily implemented predictor of SNP reproducibility. We constructed an empirical reproducibility score (RS) to simplify the prediction of reproducibility. We dichotomized each significant predictor into "0" or "1" with ones assigned to the categories associated with increased reproducibility. For example, for the conservation index (CI), which has 10 categories ( Fig. 2j ) one was assigned to category CI = 1 and zero to all others because having CI = 1 is associated with higher SNP reproducibility. The details of the scoring system we used are shown in last column of Table 3 . To compute RS we summarized individual scores for the 9 significant predictors. For the SNP type individual score can take 3 values: 0, 1 and 2 (Table 3) . Therefore, RS is an integer between 0 and 10, including 0 and 10. RS can be easily computed for any SNP in the human genome. Detailed instructions on computing of RSs are shown in supplementary materials: "Computing Reproducibility Score".
Validation of RS model
To validate the model, we used lung cancer GWAS results generated at MD Anderson Cancer Center (MDACC) (Amos et al. 2008) and International Agency for Research on Cancer (IARC) (Hung et al. 2008) . The results of these two studies were not used to build the prediction model. We assumed that if the model is effective there should be an inflation of −Log(P) among SNPs with high RSs (6 and higher).
For additional validation of the model, we used diseaseassociated SNPs that were reported in the catalog of published GWASs after we completed the analysis. One can expect that those novel, GWAS-detected SNPs will have a higher reproducibility score.
Results and discussion
Univariate analysis Figure 1 shows the relationship between −Log(P) and SNP reproducibility. SNPs were categorized into 12 groups based on −Log(P) reported for discovery studies. We observed a linear relationship between −Log(P) in the discovery study and SNP reproducibility. Mean reproducibility rate for SNPs with −Log(P) between 5 and 6 was 0.006 ± 0.001 while reproducibility rate for SNPs with −Log(P) > 20 was much higher: 0.109 ± 0.006. Table 2 shows the results of statistical analyses for other predictors. The most significant association was detected for SNP type. Other significant predictors include linked gene being a kinase reported in OMIM database. Reproducibility Rate -Log(P) category Fig. 1 The association between −Log(P) and reproducibility rate. SNPs were categorized into 12 groups based on the −Log(P) in the discovery study. Vertical bars represent standard errors Fig. 2 The association between SNP reproducibility and predictors "yes", "no" and "NA". "NA" was used for SNPs that cannot be linked to any specific gene-intergenic SNPs. We found that SNP reproducibility strongly depends on the SNP type (Fig. 2m) . We observed a significant difference in reproducibility between synonymous and nonsynonymous SNPs: 0.043 ± 0.006 for synonymous and 0.091 ± 0.006 for nonsynonymous substitutions: Mann-Whitney test, Z = 3.06, P = 0.002. It is generally accepted that the majority of the SNPs detected by GWAS are tagging SNPs. One can expect that tagging efficacy will be similar for missense and synonymous SNPs, suggesting that reproducibility for missense and synonymous SNPs will be similar if they are mostly tagging SNPs. Significantly higher reproducibility rate for missense SNPs suggests a higher proportion of causal variants among them compared to synonymous SNPs, making them a lucrative target to identify causal variants (Lewis and Tomlinson 2012; Marjoram et al. 2014) .
Selecting SNPs to construct reproducibility score (RS)
We used main-effects ANOVA to identify variables predicting SNP reproducibility independently of −Log(P). The results of the analysis are shown in Table 4 . The most significant predictor of SNP reproducibility was −Log(P). Nine out of 13 predictors were also significant: SNP type, MAF, OMIM, nuclear localization, gene size (200 kb increment), kinases, conservation index, growth factors, and tissue specific. We used two measures of SNP reproducibility. The first one-SNP reproducibility was estimated based on the results of published GWASs. SNP reproducibility is computed as a ratio of successful replications to the total number of replication attempts. SNP reproducibility is available only for GWAS-reported SNPs. We used SNP reproducibility to identify its predictors and to build the RS model. Unlike SNP reproducibility, RS can be computed for any SNP in the human genome using the algorithm described in supplementary materials. Both SNP reproducibility and RS are available for the GWAS-detected SNPs. Figure 3a shows the relationship between RS and SNP reproducibility. The dependence between the two variables is exponential: there is no difference between the group of RS 0-1 and the group of RS 2-3: Mann-Whitney U test = 1.34, P = 0.18. On the other hand, SNP reproducibility was significantly higher in the group of RS 4-5 and very high in the group RS 6-8. Interestingly, the dependence of SNP reproducibility on −Log(P) is linear (Fig. 3b) . Both −Log(P) and RS were significant in main-effects ANOVA model with similar estimated P values: 1.2 × 10 −12 for −Log(P) and 3.6 × 10 −11 for RS.
Validation of RS-based prediction of SNP reproducibility
We used the results of lung cancer GWASs conducted at MD Anderson Cancer Center (MDACC) (Amos et al. 2008) and International Agency for Research on Cancer (IARC) (Hung et al. 2008) . Adenocarcinoma and squamous cell carcinoma were analyzed separately. As a result we had 4 datasets: IARC_ADENO, IARC_SQUA-MOUS, MDACC_ADENO and MDACC_SQUAMOUS. For all genotyped SNPs, we computed RS and subdivided SNPs into 4 groups: RS = 0-1, RS = 2-3, RS = 4-5, and RS = 6-8 (Fig. 4a) . Minus Log(P) does not change much in the interval from 0 to 5 and increases for the SNPs with reproducibility score of 6 and higher. The increase in −Log(P) was significant in all groups except MDACC_SQUAMOUS.
To check if high −Log(P) in one (discovery) study predicts high −Log(P) in the other (replication) study we subdivided SNPs into 4 sets based on P values, as follows: (1) SNPs with −Log(P) between 0 and 1.3, which Therefore, we found that selection of the top SNPs based on −Log(P) was associated with a significant enrichment of the −Log(P) in one out of 4 datasets, while selection of SNPs based on RS [regardless of −Log(P)] led to a significant inflation of −Log(P) in 3 out of 4 studies. The result suggests that selection of SNPs based on RS may be more effective than selection of SNPs based on −Log(P). We hypothesized that −Log(P)-based SNP selection is more efficient for selection of most significant SNPs in the discovery study, while RS-based approach is more efficient for selection of a larger number of SNPs with smaller effect size. We estimated −Log(P) in MDACC sample among SNPs that were: (1) nominally significant in IARC; and (2) top hundred most significant IARC SNPs. We also conducted the analysis the other way around. Table 5 shows the results of the analysis. The 100 most significant SNPs in the discovery study tend to have a significantly higher −Log(P) in validation, however, SNPs nominally significant in the discovery study (P < 0.05; n = 19,000) do not show −Log(P) inflation. The result was different for RSselected SNPs. The top 100 SNPs selected based on RS do not show a −Log(P) inflation, while the top 19,000 SNPs selected based on RS (the number was chosen to match the number of nominally significant SNPs) show a significant inflation of −Log(P) in 3 out of 4 samples.
RS among disease-associated SNPs reported in recently published GWASs
When we revisited the Catalog of Published GWAS 6 months after our first visit we found 580 new diseaseassociated SNPs added to the catalog. Those SNPs were not used to build RS model and therefore can be used for validation. We computed the average RS for the novel SNPs and compared it to the average for all SNPs on the Illumina 500 k array (reference group). The average RS for the reference group was 1.43 ± 0.01 while the average RS in the group of the new disease-associated SNPs was significantly higher: 1.89 ± 0.08. Figure 5 shows the distributions of SNPs by RSs in the group of novel disease associated SNPs and in the reference group. In the group of the novel disease-associated SNPs the distribution is shifted to the right: χ 2 = 65.3, df = 9, P = 6.5 × 10 −17 .
Interactions between RS predictors
Factorial regression was used to explore second and third levels of interactions between predictors. Table 6 shows the results of the analysis.
As an example of interactions between predictors, Fig. 6 shows SNP reproducibility in four groups defined by OMIM status and SNP type. We found that missense mutations in OMIM genes have higher reproducibility than that expected from the additive model. The analysis of the third-order interactions found that SNPs that are (1) relatively rare (<10 %-but previously SNPs with higher MAFs were more reproducible), (2) missense mutations, in (3) OMIM genes have about tenfold higher reproducibility rate compared to the average reproducibility rate for the GWAS-detected SNPs.
Conclusions
SNP reproducibility is important in distinguishing true and false positives from genome-wide association studies. In this study we used the results of ~2,000 published GWASs to identify predictors of SNP reproducibility. We constructed a reproducibility score (RS) for a priory assessment of SNP reproducibility. RS is based on SNP characteristics only and does not use prior knowledge from GWAS. In most diseases GWAS-detected SNPs explain only a fraction of estimated heritability-the problem of missing heritability (Koch 2014; Shen 2013; Zuk et al. 2014) . Missing heritability may be attributable to SNPs with small effect sizes. Such SNPs are difficult to detect since a very large sample size is required. Preselecting SNPs for association study based on RS may improve detection of SNPs with small effect size because more focused approach would relax correction of the type I error for multiple testing. We believe that RS-based SNP prioritization may provide guidance for more targeted and powered approach to detecting the disease-associated SNPs with small effect size.
